First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma
Authors
Keywords
Doxorubicin, Epidermal growth factor receptor, First in human, Glioblastoma, Phase I trial
Journal
JOURNAL OF CLINICAL NEUROSCIENCE
Volume 22, Issue 12, Pages 1889-1894
Publisher
Elsevier BV
Online
2015-08-14
DOI
10.1016/j.jocn.2015.06.005

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.